TNFSF10 and neoplasm: In conjunction with the results shown in Figures 1 and 4, the data suggest that DcR3 binding to TRAIL reduces TRAIL-induced apoptosis and protects tumor cells, which might account for the resistance of tumors to TRAIL treatment.